Cancer the 'RBP'eutics–RNA-binding proteins as therapeutic targets for cancer

S Mohibi, X Chen, J Zhang - Pharmacology & therapeutics, 2019 - Elsevier
RNA-binding proteins (RBPs) play a critical role in the regulation of various RNA processes,
including splicing, cleavage and polyadenylation, transport, translation and degradation of …

Current state of “omics” biomarkers in pancreatic cancer

B Turanli, E Yildirim, G Gulfidan, KY Arga… - Journal of Personalized …, 2021 - mdpi.com
Pancreatic cancer is one of the most fatal malignancies and the seventh leading cause of
cancer-related deaths related to late diagnosis, poor survival rates, and high incidence of …

LncRNA A2M-AS1 promotes ferroptosis in pancreatic cancer via interacting with PCBP3

X Qiu, Q Shi, X Zhang, X Shi, H Jiang, S Qin - Molecular Cancer Research, 2022 - AACR
Ferroptosis is a newly-discovered cell death mechanism involved in the progression of
various tumors, the role of noncoding RNAs (ncRNAs) in it was relatively less explored. This …

SGK1 in cancer: Biomarker and drug target

J Cicenas, E Meskinyte-Kausiliene, V Jukna, A Rimkus… - Cancers, 2022 - mdpi.com
Serum-and glucocorticoid-regulated kinases (SGKs) are members of the AGC family of
serine/threonine kinases, consisting of three isoforms: SGK1, SGK2, and SGK3. SGK1 was …

Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes

C Cava, A Armaos, B Lang, GG Tartaglia… - Scientific Reports, 2022 - nature.com
Breast cancer is a heterogeneous disease classified into four main subtypes with different
clinical outcomes, such as patient survival, prognosis, and relapse. Current genetic tests for …

[HTML][HTML] Advances in poly (rC)-binding protein 2: Structure, molecular function, and roles in cancer

C Yuan, M Chen, X Cai - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Abstract Poly (rC)-binding protein 2 (PCBP2) is an RNA-binding protein that is characterized
by its ability to interact with poly (C) with high affinity in a sequence-specific manner. PCBP2 …

Systematic identification of the RNA-binding protein STAU2 as a key regulator of pancreatic adenocarcinoma

X Wang, W Kuang, J Ding, J Li, M Ji, W Chen, H Shen… - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic adenocarcinoma (PAAD) is one of the most common tumors of
the gastrointestinal tract and is difficult to diagnose and treat due to tumor heterogeneity and …

Integrating OMICS-based platforms and analytical tools for diagnosis and management of pancreatic cancer: a review

P Sousa, L Silva, JS Câmara, PG de Pinho… - Molecular …, 2025 - pubs.rsc.org
Cancer remains the second leading cause of death worldwide, surpassed only by
cardiovascular disease. From the different types of cancer, pancreatic cancer (PaC) has one …

Identification of survival-related alternative splicing signatures in acute myeloid leukemia

B Zhang, L Yang, X Wang, D Fu - Bioscience Reports, 2021 - portlandpress.com
Aberrant RNA alternative splicing (AS) variants play critical roles in tumorigenesis and
prognosis in human cancers. Here, we conducted a comprehensive profiling of aberrant AS …

Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta‑analysis of multi …

Y Ma, Y Pu, L Peng, X Luo, J Xu… - Oncology …, 2019 - spandidos-publications.com
Pancreatic duct adenocarcinoma (PDAC) is a highly malignant type of cancer with a low five‑
year survival rate. Gene alterations are crucial to the molecular pathogenesis of PDAC …